Procter & Gamble Health Limited

Web: pghealthindia.com NSE: PGHL BSE: 500126 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

6724 12(0%)

Near 52W High of 6975

Volume

14k as on 23, Jun

Open

5,436

High

5,436

Low

5,369

6,712

VWAP

6,267

52 Week High

6,975

52 Week Low

4,707

Viand Research Rating

Quality Score

67/100

Growth Score

59/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

11,162

No. of Shares

1.66

P/E

39.43

P/B

15.95

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

40.45

ROCE

Profit Growth

Listing Date

24-Apr-96

Promoter Holding

51.82%

FII Holding

6.2%

DII Holding

13.67%

Price Chart

Price Performance

1 Week0%

1 Month12%

3 Months29%

6 Months27%

1 Year27%

YTD27%

Moving Average

5 Day SMA6,262

10 Day SMA6,249

20 Day SMA6,173

30 Day SMA5,901

50 Day SMA5,596

61 Day SMA5,458

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	6,397	6,322	6,363	6,400
Resistance 2	6,363	6,317	6,339	6,364
Resistance 1	6,334	6,311	6,324	6,336
Pivot Point	6,300	6,305	6,300	6,301
Support 1	6,271	6,299	6,276	6,274
Support 2	6,237	6,293	6,261	6,238
Support 3	6,208	6,288	6,237	6,210

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,075	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,367	7284	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,71,221	5059	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,077	8838	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,13,284	1402	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,11,092	1114	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,480	2394	3%	3%	11%	25%	23	57.7	0.29	5355
8	MAXHEALTH	1,05,425	1083	2%	1%	8%	14%	0	57.7	0.32	1442
9	MANKIND	1,05,070	2544	0%	0%	18%	3%	49	57.7	0.39	1938
10	DRREDDY	97,179	1165	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%	(0.01) 51.82%
FIIs	(-0.81) 6.20%	(-0.31) 6.97%	(0.31) 7.24%	(0.11) 6.99%	(-0.11) 6.86%	(0.41) 7.01%	(0.21) 6.61%	(0.11) 6.39%	(-1.41) 6.24%	(0.21) 7.60%	(0.21) 7.38%	(0.41) 7.15%	(0.41) 6.72%	(0.31) 6.33%	(-0.41) 6.05%	(-0.11) 6.47%	(0.61) 6.57%	(0.11) 5.97%	(0.01) 5.88%
DIIs	(-0.21) 13.67%	(-0.11) 13.84%	(-0.31) 13.90%	(-0.11) 14.15%	(-0.51) 14.21%	(-0.11) 14.71%	(0.31) 14.84%	(0.81) 14.56%	(1.11) 13.72%	(0.41) 12.66%	(0.01) 12.30%	(0.01) 12.29%	(-0.11) 12.31%	(-0.21) 12.44%	(4.61) 12.62%	(0.21) 8.07%	(-0.61) 7.91%	(0.21) 8.53%	(0.01) 8.36%
Public	28.30%	27.37%	27.05%	27.03%	27.11%	26.47%	26.74%	27.24%	28.22%	27.92%	28.50%	28.74%	29.14%	29.41%	29.51%	33.64%	33.71%	33.69%	33.94%
No. of Shareholders	50,883	49,302	50,006	52,478	53,993	53,736	54,792	55,923	56,778	56,730	57,919	58,856	61,030	63,831	65,148	65,729	66,289	65,537	63,525

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	370	374	325	339	311	310	313	284	252	310	305	301	321	310	298	296	268	278	273
Sales Growth % (YoY)	19.1%	20.7%	3.7%	19.3%	23.2%	-0.1%	2.8%	-5.7%	-21.3%	-	2.5%	1.8%	19.8%	11.5%	9.1%	3.7%	22.2%	15.7%	3.4%
Sales Growth % (QoQ)	-1.1%	15.1%	-4.1%	9%	0.3%	-1%	10.2%	12.7%	-18.7%	1.6%	1.3%	-6.2%	3.5%	4%	0.7%	10.4%	-3.6%	1.8%	-
Expenses	235	263	205	248	230	186	199	236	185	208	216	256	241	201	207	237	199	216	195
Operating Profit	136	110	120	90	81	123	114	48	67	102	89	45	80	109	91	59	69	62	78
OPM %	37	30	37	27	26	40	36	17	27	33	29	15	25	35	31	20	26	22	29
Other Income	4	4	5	4	3	4	3	-18	2	5	6	5	5	5	3	3	2	5	3
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	6	6	6	5	5	6	6	7	7	7	6	6	6	8	7	7	6	7	7
Profit before tax	133	109	119	89	79	122	111	23	63	100	88	44	79	105	87	55	65	60	74
Tax %	29	29	26	25	22	25	26	26	26	28	26	32	25	27	26	25	21	25	25
Net Profit	95	78	89	66	61	91	82	17	47	72	66	30	59	77	64	41	51	45	55
Net Profit Growth % (QoQ)	21.8%	-12.4%	34.8%	8.2%	-33%	11%	382.4%	-63.8%	-34.7%	9.1%	120%	-49.2%	-23.4%	20.3%	56.1%	-19.6%	13.3%	-18.2%	-
Net Profit Growth % (YoY)	55.7%	-14.3%	8.5%	288.2%	29.8%	26.4%	24.2%	-43.3%	-20.3%	-6.5%	3.1%	-26.8%	15.7%	71.1%	16.4%	-	-	-	-
TTM Net Profit	328	294	307	300	251	237	218	202	215	227	232	230	241	233	201	192	151	100	0
EPS in Rs	56.99	46.74	53.34	39.87	36.86	54.76	49.6	10.11	28.05	43.42	39.5	17.96	35.66	46.27	38.35	24.81	30.82	27.01	33.36

Profit and Loss

	Mar 2026	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Jan 1900
Sales	1408	1151	1230	1114	1009	927	849	698	993	940	867	798	934
Sales Growth %	51%	-6%	10%	10%	-26%	9%	22%	-30%	6%	8%	8.7%	16.1%	-
Expenses	951	845	905	846	762	723	701	621	877	855	809	721	616
Operating Profit	457	307	325	268	246	204	148	77	116	85	59	77	319
OPM %	32	27	26	24	24	22	17	11	12	9	7	10	34
Other Income	17	-5	18	13	18	48	768	74	24	22	20	21	10
Interest	1	1	1	0	1	0	0	0	0	0	0	0	0
Depreciation	24	27	28	27	30	17	21	19	25	23	13	10	17
Profit before tax	450	273	314	253	233	234	895	132	115	83	67	88	312
Tax %	27	26	27	24	24	32	6	29	31	36	35	37	25
Net Profit	327	201	229	193	177	159	839	94	79	54	43	56	234
Net Profit Growth %	62.7%	-12.2%	18.7%	9%	11.3%	-81%	792.6%	19%	46.3%	25.6%	-23.2%	-76.1%	-
EPS in Rs	196.94	121.08	138.24	115.98	106.51	95.64	505.27	56.57	47.67	32.27	26.04	33.66	141.22
Dividend Payout %	211	215	69	45	122	0	87	27	23	23	23	25	89

Cash Flows

	Mar 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
Cash from Operating Activity	169	228	236	170	247	235	-130	54	107	83	5	0
Cash from Investing Activity	10	-7	-22	-26	-32	165	1270	-48	-75	-68	11	7
Cash from Financing Activity	-235	-418	-98	-289	-387	-883	-30	-22	-15	-12	-17	-5
Net Cash Flow	-56	-197	116	-145	-172	-483	1109	-16	17	4	-1	3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Dec 2024	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
Equity Capital	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17	17
Reserves	508	603	520	594	522	734	600	687	890	800	1524	717	647	575	538	506
Borrowings	9	6	8	8	10	12	3	8	0	0	0	0	0	0	0	0
Other Liabilities	308	268	250	251	247	338	269	275	269	250	219	258	215	192	154	125
Total Liabilities	841	894	794	870	794	1101	888	986	1176	1067	1759	991	879	784	708	648
Fixed Assets	102	106	116	120	128	144	112	104	101	101	104	115	111	132	110	85
CWIP	14	13	11	8	6	32	41	39	21	11	17	9	30	7	28	9
Investments	0	0	0	0	0	0	0	0	0	0	0	70	28	42	24	24
Other Assets	726	776	667	742	660	925	736	843	1053	954	1639	797	711	603	547	530
Total Assets	841	894	794	870	794	1101	888	986	1176	1067	1759	991	879	784	708	648

Delivery

#	Date	5162 35% 6975	Value (Cr)	Q/T 6	Del 54	Del 35
1	22-Jul	6712	4	3	57	2
2	21-Jul	6780	4	3	55	2
3	20-Jul	6852	7	2	58	4
4	17-Jul	6800	5	3	62	3
5	16-Jul	6854	7	3	52	4
6	15-Jul	6867	16	4	75	12
7	14-Jul	6918	29	6	63	18
8	13-Jul	6867	20	4	62	12
9	10-Jul	6839	57	6	62	35
10	9-Jul	6612	35	4	54	19
11	8-Jul	6262	22	7	66	15
12	7-Jul	6250	7	5	62	4
13	6-Jul	6351	5	4	66	3
14	3-Jul	6349	7	4	52	4
15	2-Jul	6463	6	4	66	4
16	1-Jul	6344	9	3	54	5
17	30-Jun	6326	13	5	67	9
18	29-Jun	6246	4	4	69	3
19	25-Jun	6232	5	5	73	4
20	24-Jun	6248	19	11	77	15
21	23-Jun	6204	8	3	69	6
22	22-Jun	6305	7	6	75	5
23	19-Jun	6244	8	4	60	5
24	18-Jun	6310	6	4	66	4
25	17-Jun	6250	5	5	77	4
26	16-Jun	6226	6	4	67	4
27	15-Jun	6226	6	4	60	4
28	12-Jun	6287	7	4	66	5
29	11-Jun	6207	12	5	59	7
30	10-Jun	6235	7	3	54	4
31	9-Jun	6212	4	4	56	2
32	8-Jun	6200	20	7	80	16
33	5-Jun	6200	6	5	79	5
34	4-Jun	6201	19	5	71	14
35	3-Jun	6108	8	4	62	5
36	2-Jun	6030	9	4	56	5
37	1-Jun	6063	29	6	59	17
38	29-May	6056	43	5	45	19
39	27-May	6248	305	6	23	69
40	26-May	5652	9	3	41	4
41	25-May	5726	11	4	61	7
42	22-May	5553	36	4	66	23
43	21-May	5455	14	9	85	12
44	20-May	5358	4	3	55	2
45	19-May	5340	5	4	69	4
46	18-May	5255	3	3	54	2
47	15-May	5300	5	3	57	3
48	14-May	5260	9	5	59	5

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	11,162c	72c	0.65
22-Jul	11,090c	146c	1.30
21-Jul	11,236c	68c	0.60
17-Jul	11,304c	98c	0.86
16-Jul	11,402c	28c	0.25
15-Jul	11,430c	67c	0.59
14-Jul	11,363c	95c	0.83
13-Jul	11,459c	228c	2.03
10-Jul	11,230c	276c	2.52
09-Jul	10,955c	540c	5.19
08-Jul	10,415c	11c	0.10
07-Jul	10,404c	185c	1.75
06-Jul	10,589c	43c	0.41
02-Jul	10,632c	52c	0.49
01-Jul	10,580c	97c	0.93
30-Jun	10,483c	130c	1.25
29-Jun	10,354c	4c	0.04
26-Jun	10,358c	23c	0.22
25-Jun	10,335c	47c	0.46
24-Jun	10,382c	91c	0.88
23-Jun	10,292c	166c	1.59
22-Jun	10,458c	33c	0.32
19-Jun	10,491c	166c	1.61
17-Jun	10,325c	8c	0.08
16-Jun	10,317c	42c	0.40
15-Jun	10,358c	13c	0.13
12-Jun	10,345c	12c	0.11
11-Jun	10,333c	16c	0.15
10-Jun	10,317c	0	0

Stock Checklist

Price is above from 52 week high low average: 78%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 33 fund scheme(s) across 11 fund house(s) as of Jul26 · Total value ₹1,626 Cr · 3 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Nippon India Mutual Fund	2	0.50%	-	724.8
UTI Mutual Fund	6	4.04%	-	307.6
Aditya Birla Sun Life Mutual Fund	6	0.79%	-	161
DSP Mutual Fund	2	2.64%	-	152.9
ICICI Prudential Mutual Fund	4	1.70%	-0.64%	107.2
ICICI Prudential Asset Management Company Limited	1	0.57%	+0.57%	53.6
Motilal Oswal Mutual Fund	4	0.29%	-	48.1
Tata Mutual Fund	2	1.55%	-	41
WhiteOak Capital Mutual Fund	2	1.41%	+0.80%	18.7
Baroda BNP Paribas Mutual Fund	2	1.08%	-	11.5
Bandhan Mutual Fund	2	0.30%	-	0.1

Procter & Gamble Health Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements